The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization

BACKGROUND: Transarterial chemoembolization(TACE) is the suggested treatment for hepatocellular carcinoma (HCC) not amenable to curative treatments. We investigated the role of sarcopenia on overall survival in HCC patients receiving TACE and proposed a new prognostic scoring system incorporating sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Tzu-Ping, Huang, Song-Fong, Chan, Wen-Hui, Pan, Kuang-Tse, Yu, Ming-Chin, Lee, Wei-Chen, Tsai, Hsin-I, Lin, Po-Ting, Chen, Hsing-Yu, Chen, Jui-Hsuan, Lee, Chao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554637/
https://www.ncbi.nlm.nih.gov/pubmed/36248997
http://dx.doi.org/10.3389/fonc.2022.1005571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554637/
https://www.ncbi.nlm.nih.gov/pubmed/36248997
http://dx.doi.org/10.3389/fonc.2022.1005571

Ejemplares similares